Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-susceptible Tuberculosis

被引：0

作者：

Velasquez, Gustavo E. ^{[1
,2
]}

Nahid, Payam ^{[1
,3
]}

机构：

[1] UCSF Ctr TB, San Francisco, CA 94158 USA

[2] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷 / 07期

关键词：

BACTERICIDAL ACTIVITY; MOXIFLOXACIN; PYRAZINAMIDE; PA-824; TRIAL;

D O I：

10.1164/rccm.202212-2262ED

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：816 / 818

页数：4

共 16 条

[1] [Anonymous], 2022, Global tuberculosis report 2022
[2] [Anonymous], 2022, WHO CONS GUID TUB MO
[3] Carr W, 2022, MMWR-MORBID MORTAL W, V71, P285, DOI 10.15585/mmwr.mm7108a1
[4] Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis
Conradie, Francesca
Bagdasaryan, Tatevik R. R.
Borisov, Sergey
Howell, Pauline
Mikiashvili, Lali
Ngubane, Nosipho
Samoilova, Anastasia
Skornykova, Sergey
Tudor, Elena
Variava, Ebrahim
Yablonskiy, Petr
Everitt, Daniel
Wills, Genevieve H. H.
Sun, Eugene
Olugbosi, Morounfolu
Egizi, Erica
Li, Mengchun
Holsta, Alda
Timm, Juliano
Bateson, Anna
Crook, Angela M. M.
Fabiane, Stella M. M.
Hunt, Robert
McHugh, Timothy D. D.
Tweed, Conor D. D.
Foraida, Salah
Mendel, Carl M. M.
Spigelman, Melvin
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (09) : 810 - 823
[5] Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Conradie, Francesca
Diacon, Andreas H.
Ngubane, Nosipho
Howell, Pauline
Everitt, Daniel
Crook, Angela M.
Mendel, Carl M.
Egizi, Erica
Moreira, Joanna
Timm, Juliano
McHugh, Timothy D.
Wills, Genevieve H.
Bateson, Anna
Hunt, Robert
Van Niekerk, Christo
Li, Mengchun
Olugbosi, Morounfolu
Spigelman, Melvin
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10) : 893 - 902
[6] Rifabutin for treating pulmonary tuberculosis
Davies, G.
Cerri, S.
Richeldi, L.
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04):
[7] Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
Diacon, Andreas H.
Dawson, Rodney
Hanekom, Madeleine
Narunsky, Kim
Maritz, Stefan J.
Venter, Amour
Donald, Peter R.
van Niekerk, Christo
Whitney, Karl
Rouse, Doris J.
Laurenzi, Martino W.
Ginsberg, Ann M.
Spigelman, Melvin K.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3402 - 3407
[8] Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis 12-Week Results
Dooley, Kelly E.
Hendricks, Bronwyn
Gupte, Nikhil
Barnes, Grace
Narunsky, Kim
Whitelaw, Colleen
Smit, Tanya
Ignatius, Elisa H.
Friedman, Adine
Dorman, Susan E.
Dawson, Rodney
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (07) : 929 - 935
[9] Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Dorman, S. E.
Nahid, P.
Kurbatova, E., V
Phillips, P. P. J.
Bryant, K.
Dooley, K. E.
Engle, M.
Goldberg, S., V
Phan, H. T. T.
Hakim, J.
Johnson, J. L.
Lourens, M.
Martinson, N. A.
Muzanyi, G.
Narunsky, K.
Nerette, S.
Nguyen, N., V
Pham, T. H.
Pierre, S.
Purfield, A. E.
Samaneka, W.
Savic, R. M.
Sanne, I
Scott, N. A.
Shenje, J.
Sizemore, E.
Vernon, A.
Waja, Z.
Weiner, M.
Swindells, S.
Chaisson, R. E.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18) : 1705 - 1718
[10] Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis
Ignatius, Elisa H.
Abdelwahab, Mahmoud Tareq
Hendricks, Bronwyn
Gupte, Nikhil
Narunsky, Kim
Wiesner, Lubbe
Barnes, Grace
Dawson, Rodney
Dooley, Kelly E.
Denti, Paolo
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)

← 1 2 →